Investigational Drug Information for Dutogliptin
✉ Email this page to a colleague
▶ Start for $1
Remove trial restrictions
What is the drug development status for Dutogliptin?
Dutogliptin is an investigational drug.
There have been 10 clinical trials for Dutogliptin.
The most recent clinical trial was a Phase 3 trial, which was initiated on March 1st 2009.
The most common disease conditions in clinical trials are Diabetes Mellitus, Type 2, Diabetes Mellitus, and Myocardial Ischemia. The leading clinical trial sponsors are Phenomix, Forest Laboratories, and Recardio, Inc.
Summary for Dutogliptin
| US Patents | 0 |
| International Patents | 0 |
| US Patent Applications | 196 |
| WIPO Patent Applications | 136 |
| Japanese Patent Applications | 95 |
| Clinical Trial Progress | Phase 3 (2009-03-01) |
| Vendors | 25 |
Recent Clinical Trials for Dutogliptin
| Title | Sponsor | Phase |
|---|---|---|
| Study of Dutogliptin in Combination With Filgrastim in Post-Myocardial Infarction | Recardio, Inc. | Phase 2 |
| Safety and Efficacy of Dutogliptin in Patients With Type 2 Diabetes Mellitus Receiving Background Treatment With Glimepiride Alone or in Combination With Metformin or With Pioglitazone Alone | Phenomix | Phase 3 |
| Safety and Efficacy of Dutogliptin in Patients With Type 2 Diabetes Mellitus Receiving Background Treatment With Glimepiride Alone or in Combination With Metformin or With Pioglitazone Alone | Forest Laboratories | Phase 3 |
Clinical Trial Summary for Dutogliptin
Top disease conditions for Dutogliptin
Top clinical trial sponsors for Dutogliptin
US Patents for Dutogliptin
| Drugname | Patent Number | Patent Title | Patent Assignee | Estimated Expiration |
|---|---|---|---|---|
| >Drugname | >Patent Number | >Patent Title | >Patent Assignee | >Estimated Expiration |
